INTRODUCTION
An increasing number of reports have described the existence of naturally occurring antisense transcripts in eukaryotes, suggesting that the generation of such transcripts constitutes a general mechanism for the control of gene regulation, as has been established for prokaryotes (Wagner and Simons, 1994) . Numerous examples of transcripts complementary to messenger RNAs of known function have been identified, and many such transcripts have been proposed to modulate expression of their sense counterparts at different levels ranging from DNA to protein expression, sometimes leading to various pathologies (for review see Vanhé e-Brossollet and Vaquero, 1998; Kumar and Carmichael, 1998) . In addition, some of these transcripts appeared to be potential templates for proteins, although as yet such proteins have proven difficult to characterize (Kimelman and Kirschner, 1989; Lagunoff and Roizman, 1994; Li et al., 1996) .
Some years ago, computer analysis of 12 HIV-1 isolates revealed an open reading frame (ORF) on the negative strand of the HIV-1 sequence, in a region complementary to the env gene sequence (Miller, 1988) . We and others (Michael et al., 1994; Vanhé e-Brossollet et al., 1995) have reported the existence of a natural transcript complementary to the env sequence in diverse cellular contexts. This antisense transcript was detected in various cell lines infected chronically or productively with laboratory-adapted HIV-1 isolates, as well as in T cells of patients infected with various primary isolates (Michael et al., 1994; and our unpublished results) . In agreement with these observations, transcription has been shown to be initiated from the 3Ј LTR, albeit with a lower efficiency than from its 5Ј LTR counterpart, and has given rise to the expected antisense transcript. Positive-sense RNA expression and negative-sense RNA expression do not appear to be subjected to the same regulatory signals, since a different array of cis-acting elements comes into play (Michael et al., 1994; Peeters et al., 1996) upon activation/initiation of transcription from the two HIV-1 LTRs. It has also been reported that ectopic expression of the antisense HIV-1 RNA decreased the abundance of the sense HIV-1 messenger counterparts and therefore decreased the viral yield (Kim et al., 1996; Tagieva and Vaquero, 1997) .
The antisense transcript appeared to be a potential template (Miller, 1988) for a highly hydrophobic ORF of approximately 190 amino acids in length, judging from the 12 HIV-1 isolates studied. We have provided indirect evidence for the existence of this antisense protein (ASP) by identifying, in sera of HIV-1 ϩ patients, antibodies directed against the protein obtained through an in vitro transcription and translation system (Vanhé e-Brossollet et al., 1995) . ASP could not be detected unambiguously after immunoprecipitation and Western blotting performed with lysates of infected T cells or cells overexpressing ASP, although immunofluorescence analyses performed with several antisera directed against the antisense protein or an affixed tag were indicative of the presence of the protein. In the present study, we report a computer analysis of the ASP present in the HIV-1 BRU and the successful use of immunogold labeling and electron microscopy (EM) to detect the antisense protein and define its subcellular localization in different types of cells either overexpressing ASP or infected with two different HIV-1 isolates.
RESULTS AND DISCUSSION
Computer analysis of the HIV-1 antisense proteins An antisense transcript, complementary to the HIV-1 BRU env gene in a region encompassing the cleavage site of the gp160 precursor, has been identified in infected cells (Michael et al., 1994; Vanhé e-Brossollet et al., 1995) . This transcript, moreover, appeared to encode an antisense protein of 189 aa. In an attempt to determine whether such transcripts and their putative cognate proteins were likely to be of general importance, we performed computational analyses with a large number of HIV sequences and found that the ASP sequence was well conserved among up to 550 genomic and env HIV-1 sequences of laboratory-adapted and primary HIV-1 sequences listed in the nonredundant virus library of Gen-Bank. The putative HIV-1 BRU ASP protein (EMBL Accession No. AJ310535) was particularly rich in hydrophobic amino acids (65%). Three transmembrane helices (10-26, 59-75, and 152-168) and a cytoplasmic N-terminus were predicted according to the "psort II" program (nibb.ac, Japan) indicating an association with cellular membranes. Membrane association prediction was 22% for both endoplasmic reticulum and plasma membrane and 17.5% for nuclear localization. ASP was also predicted to associate, although at a lower level, with the cell wall, mitochondria, cytoskeleton, Golgi, cytoplasm, peroxisomes, vacuoles, and vesicles of the secretary system.
In conclusion, numerous considerations, including the identification of antisense transcripts in HIV-1-infected cells, the high degree of conservation between HIV-1 BRU ASP and the antisense sequences encountered in a large number of other HIV-1 isolates and even in several SIV isolates, as well as the presence of an antisense ORF and antisense transcripts in a nonprimate lentivirus, FIV (Briquet et al., 2001) , argue in favor of the antisense transcript encoding a genuine antisense protein rather than it being a computer analysis artifact. For this reason, we used electron microscopy to confirm the expression of ASP, previously suggested by the presence of ASPspecific antibodies in the sera of HIV-1 ϩ patients ( Vanhé e-Brossollet et al., 1995) , and to define its subcellular localization in HIV-1-infected cells.
Localization of HIV-1 ASP in a T cell line overexpressing the antisense protein
In order to detect the protein, we derived several reagents including ASP expression vectors and im-mune sera (see Materials and Methods). We first examined the presence of ASP in the A3.01 T cells stably transformed with pL(VSV-AS)SN so as to overexpress the tagged ASP protein. The expression of the antisense messenger was verified by Northern blot (data not shown). A3.01 vesicular stomatitis virus (VSV)-ASP and A3.01 VSV control cells were analyzed by immunoelectron microscopy with either an anti-VSV Mab (clone P5D4) or an anti-ASP antibody as the first antibody, followed by secondary immunogold conjugates. The binding of P5D4 had been previously verified by immunoblot of a VSV fusion protein (data not shown). Binding of the rabbit anti-ASP serum obtained after immunization with three ASP peptides (1-10, 45-60, and 174-189) was assessed by recognition up to 1:10,000 dilution of the recombinant GST-ASP fusion protein (Fig. 1 , lane 1) corresponding to a unique 46-kDa band (lane 3) also revealed by the anti-GST antibody (lane 4). In contrast, no signal was detected with the preimmune serum (lane 2).
Immunogold labeling of the A3.01 VSV-ASP cells showed that ASP protein was recognized, albeit weakly, by both anti-VSV Mab (Fig. 2b ) and anti-ASP antiserum (Fig. 2c ). Interestingly, labeling was found mostly associated with the cell inner membranes and more particularly in the vicinity of mitochondria. Small clusters of gold particles (10 nm) were observed on both sides of cellular ( Fig. 2c ), nuclear (Figs. 2b and 2c), and mitochondrial ( Fig. 2b) membranes. Two control experiments were performed either with A3.01 VSV control cells incubated successively with primary and secondary antibodies or with A3.01 VSV-ASP cells incubated with the secondary antibody only ( Fig. 2a ). We then analyzed two T lymphocyte cell lines chronically or acutely infected with two different laboratoryadapted HIV-1 isolates.
FIG. 1. Assessment of the anti-ASP serum. 100 ng of GST-ASP fusion protein (46 kDa) produced in E. coli (lane 1) was analyzed by Western blot performed with a 1:10,000 dilution of preimmune serum (lane 2), with a 1:10,000 dilution of anti-ASP serum 73 days postimmunization (lane 3), and with a 1:1000 dilution of anti-glutathione S-transferase (rabbit IgG, Sigma, lane 4). Each reaction is revealed with a 1:10,000 dilution of anti-rabbit IgG peroxydase conjugate (Sigma). Prestained molecular weight markers (Biolabs) are indicated on the left.
Localization of HIV-1 ASP in ACH-2, a T cell line chronically infected with HIV-1 BRU
The ACH-2 cell line was derived from cells surviving acute infection of the A3.01 clone (a variant of the CEM-T cell line) with HIV-1 BRU . ACH-2 cells generated a small number of viruses, if any, in the absence of PMA, but upon activation by PMA (Serpente et al., 1992) produced viral transcripts, proteins, and thereafter viruses. Detection of ASP was investigated in these cells prior to and after 24 h of activation with PMA. Ultrathin sections of cells were successively incubated with the anti-ASP rabbit serum and then either the goat anti-rabbit IgG (Figs. 3d and 3e) or the F(abЈ) goat anti-rabbit IgG (Figs. 3a, 3b , 3c, 3f, and 3g) coupled to UltraSmall (US; Յ1 nm) gold particles. The coupling of IgG and F(abЈ) antibodies to US particles reduced steric hindrance of the gold conjugates, in-creased its accessibility to the antisense protein epitopes, and therefore enhanced the sensitivity of detection. All grids were further subjected to a silver enhancement reaction to increase the apparent particle size. Prior to activation, few single gold particles could be detected ( mulation of gold particles (data not presented). The two controls, incubated only with the F(abЈ) goat antirabbit gold conjugate, remained negative as shown in nonactivated and activated ACH-2 cells (Figs. 3b and  3c) .
Localization of HIV-1 ASP in cells acutely infected with HIV-1 HXB2
The SupT1 cells, which exhibit high levels of CD4, the major viral receptor, were transfected with pHXB2-MCS FIG. 3. Electron microscopy analysis of HIV-1 BRU chronically infected ACH-2 lymphocytes after immunolabeling with the anti-ASP serum. Nonactivated ACH-2 grids were incubated with 5 g/ml of anti-ASP and with a 1:100 dilution of the F(abЈ) fragment of a goat anti-rabbit IgG ultrasmall (Յ1-nm particles, Aurion) gold conjugate (a) or with F(abЈ) anti-rabbit IgG US gold conjugate alone (b). Activated ACH-2 cells were labeled with F(abЈ) anti-rabbit IgG US gold conjugate alone (c) or with 5 g/ml of anti-ASP serum and either a 1:100 dilution of a goat anti-rabbit IgG US gold conjugate (d and e) or a 1:100 dilution of the F(abЈ) anti-rabbit IgG US gold conjugate (f and g). All grids were subjected to silver enhancement. N, nucleus; n, nucleolus; scale bar, 200 nm.
(gift of N. Michael), giving rise to acute HIV-1 infection and a high yield of HIV-1 HXB2 viruses. SupT1 HXB2 cells were analyzed with the anti-ASP serum and with F(abЈ) goat anti-rabbit ultrasmall gold particles after silver enhancement. As shown in Fig. 3 , clusters of gold particles appeared to concentrate in the nucleus and in the cytoplasm ( Figs. 4c and 4f ). Labeling was also distinctly present in association with viral particles released from the cells. The virion morphology was round and of uniform size, approximately 100 nm, as expected in ultrathin sections of productive cells analyzed by electron immunocytochemistry. Depending on the orientation of the virions in the section, some rather electron-dense virions appeared to be covered by gold particles (Figs. 4c, 4d , and 4f), whereas less electron-dense particles with a clearly delineated circular lipid outer membrane were labeled just along their surface structure ( Figs. 4d and  4e ). Sections of noninfected SupT1 control cells incubated successively with anti-ASP and with the secondary US gold conjugate antibody (Fig. 4a ) as well as sections FIG. 4 . Electron microscopy analysis of HIV-1 HXB2 acutely infected SupT1 lymphocytes after immunolabeling with the anti-ASP serum. Noninfected SupT1 cell grid was incubated with 5 g/ml of anti-ASP and with a 1:100 dilution of F(abЈ) fragment of a goat anti-rabbit IgG US gold conjugate (a). Infected SupT1 HXB2 grids were labeled with F(abЈ) anti-rabbit IgG US gold conjugate alone (b) or with 5 g/ml of the anti-ASP serum and 1:100 dilution of F(abЈ) anti-rabbit IgG US gold conjugate (c, d, e, and f). All grids were subjected to silver enhancement. N, nucleus; n, nucleolus; scale bar, 200 nm.
of infected SupT1 HXB2 directly incubated with the US gold conjugate (Fig. 4b) presented no background labeling.
In summary, the data presented show that tagged ASP was produced in A3.01 cells after stable transfection with the pL(VSV-AS)SN vector and could be identified not only with a monoclonal antibody directed against the VSV portion, but also with a polyclonal antibody directed against the HIV-1 antisense protein. More interestingly, the endogenous protein was produced in cell lines infected with two different HIV-1 isolates, HIV-1 BRU and HIV-1 HXB2 . The combined use of US gold conjugates and silver enhancement in order to reduce steric hindrance and augment the number of antibody/gold entities particles bound per surface area proved essential to obtain more readily interpretable levels of labeling. Indeed, immunogold-silver techniques using US conjugates had been previously employed to label intracellular antigens associated with microtubules, ribosomes, endoplasmic reticulum, nuclear aggregates, etc. (Yi et al., 2001) . The labeling pattern of ASP was found in different cellular compartments (cytoplasm and nucleus) principally in the vicinity of the cell membranes ( Figs. 3 and 4 ). This finding is in agreement with the high degree of hydrophobicity and the potential for three transmembrane domains, as well as with the computer prediction of an intracellular localization for ASP. Finally, in Sup T1 cells acutely infected with HIV-1 HXB2 , the EM analyses revealed that ASP is not only present in productively infected cells, but is also retained in the mature viral particles released from the cells. In addition, the virus yield determined by p24 analysis of a HIV-1 HXB2 virus mutated in its capability to produce ASP without affecting Env production is clearly decreased when compared to that of the wild-type isolate (N. Michael, S.B., and C.V., personal communication) . All these considerations argue strongly in favor of ASP participation in the replicative cycle of HIV-1. Antisense transcripts and ASP might therefore be of general importance in the natural history of retroviruses and control the production of viral particles.
MATERIALS AND METHODS

Antibodies
Primary antibodies used to characterize ASP protein were as follows: anti-glutathione S-transferase (rabbit IgG, Sigma) used to identify the GST-ASP fusion protein, monoclonal anti-VSV glycoprotein (mouse IgG1, clone P5D4, provided from Sigma) directed against the tag of VSV-ASP, and a polyclonal antipeptide serum prepared by CovalAb (University of Lyon-Sud, France) directed against the antisense protein. For the latter antiserum, a New Zealand rabbit was immunized with three peptides (MPQTVSCNRC, residues 1-10; CLPAAPKNPRNKAPIP, residues 45-60 corresponding to the major hydrophilic domain; QVLLNQVLLNSCVELQ, residues 174-189) derived from the ASP amino acid sequence of HIV-1 BRU . A serum showing a high level of anti-ASP activity was obtained after the second booster inoculation (day 73) and was thus selected for use in immunochemical analyses. An anti-rabbit IgG peroxidase conjugate (Sigma) was used to analyze ASP antiserum by Western blot. Secondary antibodies used for immunogold reaction were as follows: goat anti-mouse IgG, goat anti-rabbit IgG gold conjugates (10-nm particles, Sigma), goat antirabbit IgG Ultrasmall conjugate, and F(abЈ) fragment of goat anti-rabbit IgG Ultrasmall conjugate (Յ1-nm particles, Aurion).
Virus strains
Two different isolates of HIV-1, the HIV-1 BRU isolate (Wain-Hobson et al., 1985) and the HIV-1 HXB2 molecular clone (Ratner et al., 1985) , were investigated.
Expression vectors
The pGEX-2T (Pharmacia) was used to express ASP in Escherichia coli as a fusion protein of GST with antisense HIV-1 BRU ORF obtained by PCR from the vector pE⌬H (Ellerbrok et al., 1993) using primers designed to amplify a 570-bp fragment flanked by BamHI sites. BL-21 strain transformed with pGEX-2T-ASP was grown overnight at 37°C in 2 ml of LB containing 100 g/ml ampicillin for further culture in 200 ml. After 5 h, induction was performed with 1 mM IPTG for 15 h at room temperature. Bacteria were centrifuged and the pellet was treated as described by Frangioni and Neel (1993) with 1.5% sarkosyl and 2% Triton X-100. Lysates were incubated with a 50% suspension of glutathione-agarose beads (Sigma) for 30 min at 4°C. After six washes in PBS, pH 7.4, proteins were eluted twice in 200 l of 10 mM reduced glutathione (Sigma). Proteins were subjected to electrophoresis in 10% SDS-PAGE (Laemmli, 1970) with prestained protein molecular weight markers purchased from Biolabs. Electrotransfer to PVDF filters was performed in Tris-glycine ethanol buffer (Towbin et al., 1979) and Western blot analysis was performed with anti-ASP, anti-GST, and preimmune sera followed by incubation with goat anti-rabbit peroxidase conjugate. Enzymatic activity was detected by chemoluminescence using commercially available materials (ECL kit, Amersham).
The pLXSN retroviral vector was used for stable expression of ASP tagged at its NH 2 terminus with a peptide containing the 15 COOH-terminal amino acids (497-511) of vesicular stomatitis virus glycoprotein (VSV-G) (Kreis, 1986) . The tag sequence was inserted 5Ј to the ASP sequence of the previously described pL(AS BRU )SN vector (Tagieva and Vaquero, 1997) . Briefly, the VSV-G oligonucleotide, flanked with EcoRI and XhoI restriction sites at the 5Ј and 3Ј ends, respectively, was ligated to antisense HIV-1 BRU ORF digested with BamHI. The fused fragment was then inserted into the EcoRI/BamHI sites of pLXSN, placing it under the transcriptional control of the Moloney MuSR LTR promoter (Miller and Rosman, 1989) . After sequencing was performed, retroviral CRIP packaging cells (Danos and Mulligan, 1988) were transfected with the pL(VSV-AS BRU )SN construct, as well as with the pL(VSV)SN negative control vector, in order to produce VSV-ASP expressing viruses used to infect A3.01 T cells.
The pHXB2-MCS vector, the kind gift of N. Michael, was used to transfect the SupT1 T cell line so as to obtain cells productively infected with HIV-1 HXB2 viruses (McKeating et al., 1993) .
Cells
Two lymphoid T cell lines infected with HIV-1 were selected for study. These were the chronically infected cell line ACH-2 provided by T. Folks (CDC, Atlanta), derived by acute infection of A3.01 cells with HIV-1 BRU (Folks et al., 1985) , and the SupT1 HXB2 cell line, derived by electroporation of SupT1 cells (the kind gift of V. Calvez) with pHXB2-MCS vector. The A3.01 T cell line was transduced with pL(VSV-AS BRU )SN so as to overexpress tagged VSV-ASP or with pL(VSV)SN as a negative control (see below). The cells were designated A3.01 VSV-ASP, and A3.01 VSV, respectively.
A3.01, A3.01 VSV-ASP, A3.01 VSV, ACH-2, and SupT1 cell lines were cultivated with 10% heat-inactivated fetal calf serum, 100 IU/ml of penicillin, and 100 g/ml of streptomycin in RPMI 1640 Glutamax medium. Adherent CRIP cells were grown in Dulbecco's modified Eagle's Glutamax medium, antibiotics, 10% heat-inactivated newborn calf serum. All media and supplements were purchased from Life Technologies. Transfection of CRIP packaging monolayer cells with the pL(VSV-AS BRU )SN or pL(VSV)SN vectors was performed by the calcium phosphate precipitation method with glycerol treatment. Transfected CRIP cells were then selected with 0.5 mg/ml of G418 for 3 weeks. Infection of A3.01 lymphocytic cells was carried out by coculture for 48 h with stable retroviral transformants as described in Tagieva and Vaquero (1997) . Neomycin-resistant cell populations obtained 3 weeks later, after selection with 1 mg of antibiotic/ml, were monitored for the presence of antisense RNA by Northern blot. Total RNA was extracted with commercially available materials (RNeasy kit, Qiagen) and 10 g of sample was denatured with glyoxal, subjected to electrophoresis in a 1% agarose gel, and transferred to Hybond N filter (Pall) by SSC blotting. VSV-AS RNA was detected using a specific sense riboprobe as described in Serpente et al. (1992) .
ACH-2 cells, chronically infected with HIV-1 BRU , produce few if any HIV-1 virions spontaneously. To induce viral expression, the cells were activated with 50 nM phorbol myristate acetate for 24 h (Serpente et al., 1992) . SupT1 (5 ϫ 10 6 ) cells were electroporated with 1 g of pHXB2-MCS DNA at 250 V/1500 F and immediately centrifuged for 5 min at 1500 rpm. Following resuspension of electroporated cells in 0.5 ml of complete RPMI medium, 5 ϫ 10 6 of fresh cells were added in 9.5 ml RPMI. Three to 5 days after transfection, cells exhibited a cytopathic effect and began to produce virions.
Immunochemistry
Cells were fixed with 4% paraformaldehyde, 0.5% glutaraldehyde in cacodylate buffer (0.15 M sodium cacodylate, pH 7.2), for 45 min at room temperature. After centrifugation (3000g for 5 min) cells were washed three times for 10 min in cacodylate buffer with 0.1 M NH 4 Cl. After dehydration in a graded ethanol series (50-100%), the material was embedded in LR WHITE resin (TAAB).
Ultrathin sections were transferred onto nickel EM grids, which were floated on 20-l drops of the different reagents and solutions arrayed on a sheet of Parafilm for postembedding labeling. Sections were incubated with freshly prepared 0.1% NaBH 4 for 10 min to inactivate residual aldehyde groups, rinsed twice for 5 min in PBS, pH 7.4, blocked with a commercially available solution (Blocking Solution, Aurion) for 30 min, and then washed 3ϫ for 5 min with a commercially available incubation buffer (IB, Aurion), composed of 0.1% BSAc in PBS. Incubation with primary anti-VSV (P5D4) or anti-ASP antibody (0.5 to 5 g/ml) was performed overnight at 4°C. After six washes with IB, samples were incubated for 2 h at room temperature with a 1:10 dilution of goat anti-mouse or anti-rabbit IgG conjugated with 10-nm gold particles or with a 1:100 dilution of goat anti-rabbit UltraSmall (US) or F(abЈ) goat anti-rabbit US, as the second antibody. Negative controls were either control cells before infection or transfection incubated successively with the two antibodies or cells potentially expressing ASP treated only with the secondary gold-conjugated antibody. Grids were extensively washed 6ϫ 5 min with IB and 3ϫ for 5 min with PBS, postfixed for 5 min with PBS/2% glutaraldehyde, rinsed with PBS, and finally rinsed with distilled water. The US gold clusters were increased by a silver enhancement reaction allowing detection at the EM level (van de Plas and Leunissen, 1993) . A freshly prepared mixture of Developer and Enhancer solutions, both purchased from Aurion, was applied to the specimens, as recommended by the manufacturer, for 20 min at room temperature. After uranyl acetate and lead citrate staining, specimens were examined with a Philips 201 transmission electron microscope.
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